WINNIPEG, Nov. 9, 2016 /PRNewswire/ - Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today reported its results from operations for the quarter ended September 30, 2016.
Quarter Ended September 30, 2016 Highlights:
Recorded net revenue of $8.2 million during the quarter ended September 30, 2016, an increase of 51% compared to $5.4 million for the quarter ended September 30, 2015;
Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA)1 for the quarter ended September 30, 2016 was $2.9 million compared to $2.1 million for the quarter ended September 30, 2015;
Net income for the quarter ended September 30, 2016 was $2.0 million, compared to a net loss of $348,000 for the quarter ended September 30, 2015;
